1. Home
  2. MCBS vs IVA Comparison

MCBS vs IVA Comparison

Compare MCBS & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCBS
  • IVA
  • Stock Information
  • Founded
  • MCBS 2006
  • IVA 2011
  • Country
  • MCBS United States
  • IVA France
  • Employees
  • MCBS N/A
  • IVA N/A
  • Industry
  • MCBS Major Banks
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MCBS Finance
  • IVA Health Care
  • Exchange
  • MCBS Nasdaq
  • IVA Nasdaq
  • Market Cap
  • MCBS 654.0M
  • IVA 769.0M
  • IPO Year
  • MCBS 2019
  • IVA 2020
  • Fundamental
  • Price
  • MCBS $25.76
  • IVA $4.10
  • Analyst Decision
  • MCBS Hold
  • IVA Strong Buy
  • Analyst Count
  • MCBS 1
  • IVA 7
  • Target Price
  • MCBS $31.00
  • IVA $16.57
  • AVG Volume (30 Days)
  • MCBS 40.6K
  • IVA 363.0K
  • Earning Date
  • MCBS 10-17-2025
  • IVA 09-29-2025
  • Dividend Yield
  • MCBS 3.88%
  • IVA N/A
  • EPS Growth
  • MCBS 11.15
  • IVA N/A
  • EPS
  • MCBS 2.59
  • IVA N/A
  • Revenue
  • MCBS $147,349,000.00
  • IVA $19,929,536.00
  • Revenue This Year
  • MCBS $18.90
  • IVA N/A
  • Revenue Next Year
  • MCBS $27.50
  • IVA N/A
  • P/E Ratio
  • MCBS $9.96
  • IVA N/A
  • Revenue Growth
  • MCBS 8.69
  • IVA N/A
  • 52 Week Low
  • MCBS $24.24
  • IVA $2.11
  • 52 Week High
  • MCBS $36.15
  • IVA $7.98
  • Technical
  • Relative Strength Index (RSI)
  • MCBS 38.44
  • IVA 39.58
  • Support Level
  • MCBS $25.14
  • IVA $3.79
  • Resistance Level
  • MCBS $26.64
  • IVA $4.42
  • Average True Range (ATR)
  • MCBS 0.61
  • IVA 0.76
  • MACD
  • MCBS 0.01
  • IVA -0.16
  • Stochastic Oscillator
  • MCBS 28.05
  • IVA 7.50

About MCBS MetroCity Bankshares Inc.

MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: